The activation of AKT depends on Ca2+ through TRPC1 in lung cancer and hepatocellular carcinoma cell lines [71,72], and the activation of ERK1/2 depends on Ca2+ through TRPC1 in thyroid and different breast cancer cell lines [29,73,74]. Here, AKT1 is linked to hepatocellular carcinoma.